Source: International Congress 2016 – Novel avenues in the treatment of COPD II
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Suleyman Savas Hacievliyagil (Malatya, Turkey), Ünal Akel, Süleyman Savas Hacievliyagil, Zeynep Ayfer Aytemur, Saim Yologlu, Saltuk Bugra Kaya, Nazan Akel. Direct cost analysis of COPD patients: A 1 year follow-up study. Eur Respir J 2016; 48: Suppl. 60, 4070

Member's Comments

No comment yet.

Related content which might interest you: Four years follow-up of exacerbations in a cohort of COPD patients: 1 year interim results (EXACO study) Source: Annual Congress 2008 - COPD - clinical and epidemiological aspects Year: 2008 Outcomes in patients with COPD during a 3 year follow-up Source: International Congress 2015 – Clinical assessment and monitoring of asthma and COPD Year: 2015 Pharmacoeconomic evaluation of COPD: A 1 year follow-up study Source: Annual Congress 2010 - Influence of delivery of care on outcome parameters: therapy is more than medication prescription Year: 2010 Three year follow-up of distribution and stability of patients with COPD according GOLD 2014 Source: International Congress 2015 – Clinical assessment in asthma and COPD Year: 2015 Analysis of the frequency of COPD exacerbations in the ’real-life’ DACCORD study over a 2 year period Source: International Congress 2016 – Comorbidities and exacerbations in COPD Year: 2016 Effect of non-invasive mechanical ventilation on exacerbations in patients with stable COPD: A 4 year cohort study with one year follow-up Source: International Congress 2015 – Novelties in noninvasive ventilation Year: 2015 Long-term benefits of pulmonary rehabilitation in COPD patients: 2 year follow-up Source: International Congress 2017 – Novel treatments for rehabilitation of patients with chronic respiratory diseases Year: 2017 The cost analysis of our COPD patients Source: Eur Respir J 2006; 28: Suppl. 50, 38s Year: 2006 Exacerbations in a cohort of COPD patients: frequent exacerbators characteristics after 1-year follow-up (EXACO study – interim analysis) Source: Annual Congress 2008 - COPD - clinical and epidemiological aspects Year: 2008 Real-life COPD patients compared to large trial populations: An UNLOCK external validity study Source: Annual Congress 2013 –Management of respiratory diseases in primary care Year: 2013 Change of COPD maintenance medication over two years in a large real life cohort: The DACCORD study Source: International Congress 2016 – In-patient and out-patient COPD management Year: 2016 An integrated disease management (IDM) programme of 12 months duration was effective for patients with COPD Source: International Congress 2016 – COPD diagnosis and management Year: 2016 2 years in the life of COPD patients: Evolution of GOLD 2011 classification in the ’real-life’ DACCORD study Source: International Congress 2016 – Comorbidities and exacerbations in COPD Year: 2016 Efficacy of tiotropium/olodaterol on sedentary/active time in COPD patients: VESUTO study Source: International Congress 2018 – COPD management Year: 2018 COPD management in general practice –One year follow-up of the Swiss COPD cohort study Source: Annual Congress 2010 - Pharmacological treatment in primary care Year: 2010 Changes in prescriped inhaled COPD medication during a 3 year period in Denmark. A registry study Source: Annual Congress 2013 –Quality of life and respiratory symptoms in primary care COPD populations Year: 2013 Patients’ adherence to treatment: How does it changes in 1 year after finishing of the participation in trial? Source: Annual Congress 2013 –New treatments and old dilemmas in the clinical management of lung diseases Year: 2013 Short-term evaluation of a remote patient support program in patients with COPD and frequent exacerbations. ESOPO study Source: International Congress 2015 – Asthma and COPD: overlap and exacerbations Year: 2015 The cost of COPD: results from the SIRIBO study Source: Eur Respir J 2002; 20: Suppl. 38, 125s Year: 2002 Influence of patient baseline characteristics and concomitant medication on outcomes in long-term trials of COPD: Analysis of the UPLIFT® trial Source: Annual Congress 2013 –Clinical trials of LAMAs, LABAs, MABAs and theophylline for asthma and COPD Year: 2013